Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma
Gazyva (obinutuzumab) - Roche, Biogen
'New kids on the block' – Real-world experience of Belimumab, Obinutuzumab and Voclosporin in Systemic Lupus Erythematosus (SLE): A Retrospective Cohort Study at UCLH (LUPUS 2026) - Feb 17, 2026 - Abstract #PO:11:278; 6; Pres time: Mar 6, 2026; 07:30 AM - 07:30 PM; Location: Poster Area; "Voclosporin improved proteinuria and serology but limited by rising creatinine. Continued follow-up will determine durability of response and long-term safety of these agents." 
Real-world • Real-world evidence • Retrospective data • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Systemic Lupus Erythematosus
https://lupus.bmj.com/content/13/Suppl_1/A281.2
 
Soon Chin Toh; Akanksha Sinha; Vikram Joseph; Maria Leandro; Ruth Pepper; David Isenberg
 
Feb 17, 2026
 
Prev Next